Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2003
06/11/2003CN1423697A Virulence genes and proteins and their use
06/11/2003CN1423695A Antisense oligonucleotides
06/11/2003CN1423694A Site-directed mutagenesis of escherichia coli phytase
06/11/2003CN1423693A Method for the production of vitamin A
06/11/2003CN1423692A Human Muellerian Duct-derived epithelial cells and methods of isolation and uses thereof
06/11/2003CN1423691A Process for producing L-lysine
06/11/2003CN1423660A Antibodies
06/11/2003CN1423659A Recombinant gelatins
06/11/2003CN1423658A Modulation of human sodium channels in dorsal root ganglia
06/11/2003CN1423657A Inter feron-alpha induced gene
06/11/2003CN1423654A Synthesis of 2'-deoxy-L-nucleosides
06/11/2003CN1423565A 精子因子oscillogenin Sperm factor oscillogenin
06/11/2003CN1423563A Pancreatic stem cells and their use in transplantation
06/11/2003CN1423523A Human ex vivo immune system
06/11/2003CN1423522A A method to produce cloned embryos and adults from cultured cells
06/11/2003CN1423521A In OVO activation of an avian egg in the shell
06/11/2003CN1423520A Compositions and methods for modulation of plant cell division
06/11/2003CN1422963A RET oligo-nucleotide microchip and method for detecting genetic cancer
06/11/2003CN1422959A Secondary lymphoid chemotactic factor SLC preparation method
06/11/2003CN1422958A Human vascular endothelial growth factor and its polyclonal antibody preparation and method for constructing eukaryotic expression vector
06/11/2003CN1422955A Water pore protein promoter of germinal specific expression of rapeseed and its use
06/11/2003CN1422954A Human interferon alpha 2a gene cDNA code modification recombination sequence
06/11/2003CN1422953A Gene sequence of Japanese shistosome China mainland strain gynecophoric canal protein
06/11/2003CN1422952A Human interferon alpha 2b gene cDNA code modification recombination sequence
06/11/2003CN1422950A Recombinant gland-related virus expressing human blood angiotonin II receptor I antisense gene and preparation method thereof
06/11/2003CN1422949A Method for producing and converting manioc protoplasm
06/11/2003CN1422870A Fusional protein with intensified activity of internal red-blood-cell formation element
06/11/2003CN1422868A Receptor targeting chimeric toxin with junctional sequence
06/11/2003CN1422864A Zinc finger protein and its antibody preparation and use
06/11/2003CN1422863A Recombinant chimeric peptide antigen detecting HCMV antibody and production method thereof
06/11/2003CN1422665A Method for producing marker vaccinum of resisting mammal virus
06/11/2003CN1422610A Peparation of human recombined blood-vessel generation element and skin whitening product
06/11/2003CN1111283C Process for preparing human placenta lactogen as diagnostic blood corpuscle immunodiffusion plate
06/11/2003CN1111200C Recombinant fish growth hormone gene engineering yeast pichia pastoris
06/11/2003CN1111199C High-efficient biological reactor for transgenosis chlorella
06/11/2003CN1111198C Human megacaryocyte poietin and its purification, CDNA clone and recombin protein preparation method and use
06/10/2003US6576820 Rice cell transformed with a gene encoding the protein; useful as an ingredient in food and for preventing and treating arteriosclerosis and coronary heart diseases; lowers serum cholesterol
06/10/2003US6576819 Methods for modulating the levels of organic sulfur compounds in plants by transforming with (P)APS reductase DNA
06/10/2003US6576818 Isolated polynucleotide of given sequence; use in altering the phenotype of cotton fiber
06/10/2003US6576816 Heavy metal phytoremediation
06/10/2003US6576815 Promoter sequence expressed in anthers and pollens
06/10/2003US6576814 Decreasing the expression of a nucleotide sequence; corn
06/10/2003US6576813 Knockout animals
06/10/2003US6576811 Transgenic rat with human normal type c-Ha-ras gene
06/10/2003US6576759 Antiproliferative agents; anticancer agents; rheumatic disorders; administering nucleotide
06/10/2003US6576758 Nucleic acid constructs containing hybrid promoters
06/10/2003US6576757 Polynucleotides encoding flavivirus and alphavirus multivalent antigenic polypeptides
06/10/2003US6576756 Nucleotide sequences coding polypetide for use in the diagnosis and treatment of cancer
06/10/2003US6576755 Beta-defensins
06/10/2003US6576751 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
06/10/2003US6576745 Human cystatin F antibodies
06/10/2003US6576744 Cytokine receptor zalpha11
06/10/2003US6576743 Of given amino acid sequence; useful for promoting wound healing and stimulating platelet proliferation; can use in treating autoimmune diseases and cancer
06/10/2003US6576609 Methods and compositions for generating angiostatin
06/10/2003US6576608 Stimulating tyrosine phosphorylation of Flt4 tyrosine kinase receptor in Flt4-expressing cell
06/10/2003US6576469 Inducible methods for repressing gene function
06/10/2003US6576468 Methods for obtaining microbe-resistant mammalian cells from hypermutable mammalian cells
06/10/2003US6576467 Methods for producing recombined antibodies
06/10/2003US6576464 Methods for providing differentiated stem cells
06/10/2003US6576463 Nucleic acid molecule comprising adenoviral region with inverted terminal repeats; retroviral region comprising promoter and long terminal repeats; provides efficient transduction of cells and stable integration
06/10/2003US6576456 Chimeric adenovirus fiber protein
06/10/2003US6576455 Structure-based designed herbicide resistant products
06/10/2003US6576454 One or more amino acid residues being replaced by cysteine residues where at least some of cysteine residues are modified by replacing thiol hydrogen in cysteine residue with thiol side chain to form modified enzyme
06/10/2003US6576453 Thermostable DNA ligase mutants
06/10/2003US6576452 Isolated nucleic acid molecule comprising a nucleotide sequence which encodes a polypeptide of given amino acid sequence; use for biological conversion of glucose to ascorbic acid
06/10/2003US6576450 Generating polyhydroxyalkanoates; obtain genetically cells which express enzymes associated with generation of polyhydroxyalanoates, incubate with 3-hydroxypropionate or 3-hydroxyvalerate, recover polyhydroxyalkonoates
06/10/2003US6576447 Suppressing the action of nucleic acid synthesis inhibitory substances and thereby amplifying a nucleic acid with an insoluble polymer of a polyanion, especially a sulfated sulfated polysaccharide
06/10/2003US6576443 Adjustment of gene expression
06/10/2003US6576442 rdgB proteins and related products and methods
06/10/2003US6576441 Isolated nucleic acid comprising a polynucleotide of given sequence; collapses growth cones of dorsal root ganglion cells and inhibits neurite outgrowth; can use in central nervous system neuron regeneration
06/10/2003US6576439 Contacting protein of given sequence with a test compound and detecting modulating activity; drug screening; can use for treatment of inflammatory conditions
06/10/2003US6576437 Stimulus-inducible protein kinase complex and methods of use therefor
06/10/2003US6576434 Transport protein of given amino acid sequence; exposing cells that express the protein to compound; measuring ion transport; use in treatment of interleukin mediated atopic allergy, asthma and cystic fibrosis
06/10/2003US6576427 Human cartilage glycoprotein
06/10/2003US6576426 Tag reagent and assay method
06/10/2003US6576422 Interaction between marker ligand and ligand binding domain of detector composition (nucleotide sequences encoding transcription factors) produces a detectable signal
06/10/2003US6576341 Composition
06/10/2003US6576243 Polynucleotide vaccine formula against porcine reproductive and respiratory pathologies
06/10/2003US6576237 Vertebrate tissue pattern-inducing proteins, and uses related thereto
06/10/2003US6576234 Reovirus for the treatment of neoplasia
06/10/2003US6576218 Transplacental delivery of oligonucleotides
06/10/2003CA2234183C Dual chamber disposable reaction vessel for amplification reactions, reaction processing station therefor, and methods of use
06/10/2003CA2191795C Antisense oligonucleotide modulation of raf gene expression
06/10/2003CA2166367C Live recombinant avian vaccine using an avian herpesvirus as vector
06/10/2003CA2121121C Preparation of recombinant borrelia proteins
06/10/2003CA2108579C Genetic markers for pig litter size
06/10/2003CA2081879C Monoclonal antibodies to polyacrylate polymers
06/10/2003CA2076652C Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase
06/10/2003CA2065323C Isolation and purification of lung surfactant protein
06/07/2003CA2376719A1 A method to improve the safety of gene therapy
06/07/2003CA2364741A1 Transgenic plants having reduced susceptibility to invertebrate pests
06/05/2003WO2003046581A2 Methods for diagnosis and treatment of epithelial-derived cancers,such as colorectal cancers and kidney cancers
06/05/2003WO2003046552A2 Screening method for compounds that modulate neuronal activity
06/05/2003WO2003046511A2 Magneto-optical bio-discs and systems including related methods
06/05/2003WO2003046506A2 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies
06/05/2003WO2003046226A1 Methylotrophic bacterium for the production of recombinant proteins and other products
06/05/2003WO2003046215A1 Method for detecting hybridization events in nucleic acids
06/05/2003WO2003046214A2 Method for analyzing translation-controlled gene expression
06/05/2003WO2003046212A2 Method for identifying target epitopes of the t cell mediated immune response and for assaying epitope-specific t cells
06/05/2003WO2003046209A2 Method and biosensor for detecting macromolecular biopolymers